Angela M. Crook - Publications

Preserved Spermatogenesis and Hormonal Function in Men Receiving a Pretomanid Regimen (BPaMZ) for Pulmonary Drug-Resistant Tuberculosis.

Journal: Clinical pharmacology and therapeutics

Published: November 25, 2025

Effectiveness and safety of shortened intensive treatment for children with tuberculous meningitis (SURE): a protocol for a phase 3 randomised controlled trial evaluating 6 months of antituberculosis therapy and 8 weeks of aspirin in Asian and African children with tuberculous meningitis.

Journal: BMJ open

Published: April 03, 2025

Designing a response-over-continuous-intervention (ROCI) randomised trial: Implementation in the Phase 2C part (duration ranging) of the PARADIGM4TB trial.

Journal: Contemporary clinical trials

Published: January 14, 2025

Optimal dosing and duration of linezolid for the treatment of multidrug-resistant and rifampicin-resistant tuberculosis: an individual patient data meta-analysis.

Journal: The European respiratory journal

Published: December 07, 2024

Approaches and processes for paediatric chest X-ray classification used in the SHINE TB treatment-shortening trial.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: October 29, 2024

Efficacy and safety of 8-week regimens for the treatment of rifampicin-susceptible pulmonary tuberculosis (TRUNCATE-TB): a prespecified exploratory analysis of a multi-arm, multi-stage, open-label, randomised controlled trial.

Journal: The Lancet. Infectious diseases

Published: October 24, 2024

Target regimen profiles for tuberculosis treatment.

Journal: Bulletin of the World Health Organization

Published: May 06, 2024

A publicly accessible global data repository - the WHO TB-IPD platform.

Journal: IJTLD open

Published: March 17, 2024

T-wave morphology abnormalities in the STREAM stage 1 trial.

Journal: Expert opinion on drug safety

Published: March 11, 2024

Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial.

Journal: The Lancet. Infectious diseases

Published: December 18, 2023

Clinical Outcomes in Children With Human Immunodeficiency Virus Treated for Nonsevere Tuberculosis in the SHINE Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: December 08, 2023

Inadequate Lopinavir Concentrations With Modified 8-Hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIV.

Journal: The Pediatric infectious disease journal

Published: July 28, 2023